Videos
Ruben Mesa, MD, discusses the current state of the treatment landscape for patients with myeloproliferative neoplasms.
Joseph Chao, MD, discusses the importance of assessing the microsatellite instability (MSI) status in patients with advanced gastric/gastroesophageal junction cancer based on findings from a comparative analysis of KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062.
Managing A Case of Heavily Pretreated Recurrent Ovarian Cancer
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
PLT012 Receives IND Clearance from FDA for Solid Tumors
2
Roxadustat Granted Orphan Drug Designation for Myelodysplastic Syndromes
3
Targeting HER2-Low Breast Cancer: the ARX788 Phase 2 Clinical Trial
4
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
5